UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000027982
Receipt No. R000032023
Official scientific title of the study Randomized controlled trials evaluating the necessity of antimicrobial prophylaxis in colorectal endoscopic submucosal dissection
Date of disclosure of the study information 2017/07/01
Last modified on 2017/06/29 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Randomized controlled trials evaluating the necessity of antimicrobial prophylaxis in colorectal endoscopic submucosal dissection
Title of the study (Brief title) Necessity of antibiotics to colonic ESD
Region
Japan

Condition
Condition colorectal cancer
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To clarify the necessity of antibiotic in colorectal endoscopic submucosal dissection
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes postoperative fever
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 No administration of antibiotics during the perioperative period
Interventions/Control_2 Intravenous administration of cefotiam(2.0g per day)for three days
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Colorectal tumor meeting Japanese
guidelines for colorectal cancer
Key exclusion criteria 1)Patients taking oral steroids or immunosuppressants
2)Patients with an immunosuppressive disease(blood diseases, HIV etc.)
3)Patients with an allergy to Cefotiam
4)Patients deemed inapprorriate
Target sample size 160

Research contact person
Name of lead principal investigator Shinwa Tanaka
Organization Kobe University
Division name Gastroenterology
Address 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
TEL 078-382-6305
Email tanakas@med.kobe-u.ac.jp

Public contact
Name of contact person Hiroya Sakaguchi
Organization Kobe University
Division name Gastroenterology
Address 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
TEL 078-382-6305
Homepage URL
Email skgch@med.kobe-u.ac.jp

Sponsor
Institute Kobe University
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 07 Month 01 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 08 Month 01 Day
Anticipated trial start date
2017 Year 08 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 06 Month 28 Day
Last modified on
2017 Year 06 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032023